SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Abraxis BioScience, Inc. Release: Among the Toughest Cancers to Treat, New ABRAXANE(R) Data Demonstrates Potential in Patients with Advanced and Malignant Melanoma